CAVALLO, Federica
 Distribuzione geografica
Continente #
NA - Nord America 2.547
EU - Europa 1.387
AS - Asia 978
SA - Sud America 61
OC - Oceania 49
AF - Africa 30
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.054
Nazione #
US - Stati Uniti d'America 2.447
IT - Italia 448
CN - Cina 391
DE - Germania 210
IN - India 180
JP - Giappone 137
NL - Olanda 134
GB - Regno Unito 123
CA - Canada 83
FR - Francia 77
ES - Italia 74
VN - Vietnam 61
RU - Federazione Russa 46
KR - Corea 45
PL - Polonia 45
CZ - Repubblica Ceca 42
IE - Irlanda 39
AU - Australia 37
CH - Svizzera 30
TR - Turchia 24
DK - Danimarca 22
HK - Hong Kong 21
TW - Taiwan 18
ZA - Sudafrica 18
BR - Brasile 17
CO - Colombia 16
PH - Filippine 16
TH - Thailandia 15
IL - Israele 14
MX - Messico 14
ID - Indonesia 13
CL - Cile 12
HU - Ungheria 12
NZ - Nuova Zelanda 12
GR - Grecia 11
RO - Romania 11
SA - Arabia Saudita 11
BE - Belgio 10
SG - Singapore 9
PT - Portogallo 8
NG - Nigeria 7
IQ - Iraq 6
AR - Argentina 5
AT - Austria 5
FI - Finlandia 5
NO - Norvegia 5
PK - Pakistan 5
SE - Svezia 5
UA - Ucraina 5
IR - Iran 4
LT - Lituania 4
MK - Macedonia 4
MY - Malesia 4
PE - Perù 4
EC - Ecuador 3
BG - Bulgaria 2
IM - Isola di Man 2
LV - Lettonia 2
RS - Serbia 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BO - Bolivia 1
CU - Cuba 1
EG - Egitto 1
ET - Etiopia 1
EU - Europa 1
JO - Giordania 1
KE - Kenya 1
KH - Cambogia 1
KZ - Kazakistan 1
MA - Marocco 1
NP - Nepal 1
PA - Panama 1
SV - El Salvador 1
VE - Venezuela 1
ZW - Zimbabwe 1
Totale 5.054
Città #
Fairfield 249
Houston 182
Woodbridge 151
Ashburn 145
Seattle 125
Santa Cruz 114
Buffalo 113
Ann Arbor 98
Wilmington 96
Torino 94
Cambridge 89
Beijing 70
Shanghai 49
Dong Ket 46
Duncan 41
Chicago 37
Chennai 32
Warsaw 32
Dublin 31
Tokyo 31
Pisa 30
Turin 30
University Park 28
Bengaluru 27
Wuhan 25
Fleming Island 24
Milan 23
San Diego 22
Nanjing 21
Guangzhou 20
Los Angeles 20
Almere 19
New York 18
Clearwater 17
Mountain View 17
Rochester 17
Rome 17
Sannomaru 17
Boardman 15
Collegeville 15
Taipei 15
Las Vegas 14
London 14
Montreal 14
Muizenberg 14
Nuenen 14
Randers 14
Chengdu 13
Norwalk 13
Hyderabad 12
Ottawa 12
Ankara 11
Lake Forest 11
Phoenix 11
Toronto 11
Zhengzhou 11
Alkmaar 10
Bogotá 10
Dearborn 10
Des Moines 10
Florence 10
Hangzhou 10
Nanning 10
Pinerolo 10
San Francisco 10
Shenyang 10
Coimbatore 9
Dallas 9
Henderson 9
Mumbai 9
Nürnberg 9
Paris 9
Sydney 9
Tianjin 9
Xian 9
Atlanta 8
Barcelona 8
Changsha 8
Jerusalem 8
Leawood 8
Madrid 8
Raritan 8
Rotterdam 8
Central 7
Columbus 7
Durham 7
San Jose 7
Varallo Pombia 7
Boston 6
Chiba 6
Delhi 6
Enschede 6
Gainesville 6
Jinan 6
Lausanne 6
Oberboihingen 6
Riva 6
Tappahannock 6
Tong 6
Abadiano 5
Totale 2.802
Nome #
ROBUST: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell Lymphoma, file e27ce431-ebfa-2581-e053-d805fe0acbaa 498
ABVD vs BEACOPP escalated in advanced-stage Hodgkin’s lymphoma: Results from a multicenter European study, file e27ce432-1790-2581-e053-d805fe0acbaa 441
Italian consensus conference for the outpatient autologous stem cell transplantation management in multiple myeloma, file e27ce428-a06a-2581-e053-d805fe0acbaa 405
Selinexor in patients with relapsed or refractory diffuse large B-cell lymphoma (SADAL): a single-arm, multinational, multicentre, open-label, phase 2 trial, file e27ce430-3945-2581-e053-d805fe0acbaa 360
Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patients., file e27ce426-d3d5-2581-e053-d805fe0acbaa 282
The role of pre-transplant induction regimens and autologous stem cell transplantation in the era of novel targeted agents, file e27ce427-812e-2581-e053-d805fe0acbaa 278
Role of consolidation/maintenance therapy in multiple myeloma., file e27ce427-0f1c-2581-e053-d805fe0acbaa 249
Continuous Therapy Versus Fixed Duration of Therapy in Patients With Newly Diagnosed Multiple Myeloma, file e27ce435-5f64-2581-e053-d805fe0acbaa 245
High-risk myeloma: when to transplant-or not., file e27ce427-8e9d-2581-e053-d805fe0acbaa 228
Bortezomib (Velcade) for progressive myeloma after autologous stem cell transplantation and thalidomide, file e27ce426-aea7-2581-e053-d805fe0acbaa 195
Outcome of transformed follicular lymphoma worsens according to the timing of transformation and to the number of previous therapies. A retrospective multicenter study on behalf of Fondazione Italiana Linfomi (FIL), file e27ce42f-951a-2581-e053-d805fe0acbaa 191
Autologous Transplantation and Maintenance Therapy in Multiple Myeloma, file e27ce432-dc72-2581-e053-d805fe0acbaa 185
Lenalidomide plus R-CHOP21 in newly diagnosed diffuse large B-cell lymphoma (DLBCL): long-term follow-up results from a combined analysis from two phase 2 trials, file e27ce42d-9062-2581-e053-d805fe0acbaa 165
A retrospective study of R-DHAP/Ox for early progressing follicular lymphoma., file e27ce42d-42dd-2581-e053-d805fe0acbaa 163
Highly sensitive MYD88 l265p mutation detection by droplet digital polymerase chain reaction in waldenström macroglobulinemia, file e27ce42c-516f-2581-e053-d805fe0acbaa 158
Lenalidomide in the treatment of plasma cell dyscrasia: state of the art and perspectives., file e27ce427-86a7-2581-e053-d805fe0acbaa 129
CNS relapse in patients with DLBCL treated with lenalidomide plus R-CHOP (R2CHOP): Analysis from two phase 2 studies, file e27ce42d-2448-2581-e053-d805fe0acbaa 125
Integration of COO into the clinical CNS International Prognostic Index could improve CNS relapse prediction in DLBCL, file e27ce42f-3b10-2581-e053-d805fe0acbaa 119
Early progression as a predictor of survival in marginal zone lymphomas: An analysis from the FIL-NF10 study, file e27ce430-3a9e-2581-e053-d805fe0acbaa 117
Droplet Digital PCR Assay for MYD88L265P, file e27ce42f-575c-2581-e053-d805fe0acbaa 116
Psychological distress and oral chemotherapy: a pilot study., file e27ce428-dbf5-2581-e053-d805fe0acbaa 103
Simplified Geriatric Assessment in Older Patients With Diffuse Large B-Cell Lymphoma: The Prospective Elderly Project of the Fondazione Italiana Linfomi, file e27ce431-f034-2581-e053-d805fe0acbaa 100
Real life use of bendamustine in elderly patients with lymphoid neoplasia, file e27ce432-2046-2581-e053-d805fe0acbaa 73
MET dysregulation is a hallmark of aggressive disease in multiple myeloma patients, file e27ce426-f87f-2581-e053-d805fe0acbaa 57
Oral chemotherapy: an innovative choice, file e27ce42a-54df-2581-e053-d805fe0acbaa 47
Health-related quality of life and utility outcomes with selinexor in relapsed/refractory diffuse large B-cell lymphoma, file e27ce431-d75f-2581-e053-d805fe0acbaa 44
Dissecting MRD Kinetics By Automated Computational Analysis to Improve Outcome Prediction in Mantle Cell Lymphoma: A Bioinformatic Substudy from the Fondazione Italiana Linfomi (FIL) MCL0208 Clinical Trial, file 8147eea1-ed6e-4c9e-b8de-b8d70eeee4cc 31
Difference in outcome between curative intent vs marginal excision as a first treatment in dogs with oral malignant melanoma and the impact of adjuvant CSPG4-DNA electrovaccination: A retrospective study on 155 cases, file e27ce432-c7ad-2581-e053-d805fe0acbaa 29
Obinutuzumab and miniCHOP for unfit patients with diffuse large B-cell lymphoma. A phase II study by Fondazione Italiana Linfomi, file e27ce42e-e4a5-2581-e053-d805fe0acbaa 28
COMPREHENSIVE ANALYSIS OF BASELINE OUTCOME BIOPREDICTORS IN YOUNGER PATIENTS WITH MANTLE CELL LYMPHOMA: THE ANCILLARY BIOLOGICAL STUDIES OF FONDAZIONE ITALIANA LINFOMI (FIL) MCL0208 CLINICAL TRIAL, file e27ce42e-6cf2-2581-e053-d805fe0acbaa 23
Highly sensitive MYD88 l265p mutation detection by droplet digital polymerase chain reaction in waldenström macroglobulinemia, file e27ce435-9268-2581-e053-d805fe0acbaa 20
COMPREHENSIVE ANALYSIS OF BASELINE OUTCOME BIOPREDICTORS IN YOUNGER PATIENTS WITH MANTLE CELL LYMPHOMA: THE ANCILLARY BIOLOGICAL STUDIES OF FONDAZIONE ITALIANA LINFOMI (FIL) MCL0208 CLINICAL TRIAL, file e27ce42e-6cf3-2581-e053-d805fe0acbaa 14
HBV Reactivation in Patients with Past Infection Affected by Non-Hodgkin Lymphoma and Treated with Anti-CD20 Antibody Based Immuno-Chemotherapy: A Multicenter Experience, file ddc47db0-3197-4479-9923-bf2f533cc0e7 13
Case Report: Sequential Development of Three Mature Lymphoid Neoplasms in a Single Patient: Clonal Relationship and Molecular Insights, file 79f96122-4c5d-4b19-a66a-786e84540e13 12
The Association between Patient Characteristics and the Efficacy and Safety of Selinexor in Diffuse Large B-Cell Lymphoma in the SADAL Study, file c488247a-de2b-44cc-9b8b-691265b21404 7
Progressive telomere shortening is part of the natural history of chronic lymphocytic leukaemia and impacts clinical outcome: Evidences from long term follow-up, file e27ce42c-a111-2581-e053-d805fe0acbaa 7
Selinexor in patients with relapsed or refractory diffuse large B-cell lymphoma (SADAL): a single-arm, multinational, multicentre, open-label, phase 2 trial, file e27ce42f-c137-2581-e053-d805fe0acbaa 7
Netupitant-palonosetron to prevent chemotherapy-induced nausea and vomiting in multiple myeloma patients receiving high-dose melphalan and autologous stem cell transplantation, file e27ce430-1511-2581-e053-d805fe0acbaa 6
Diffuse large B-cell lymphoma in octogenarians aged 85 and older can benefit from treatment with curative intent: a report on 129 patients prospectively registered in the Elderly Project of the Fondazione Italiana Linfomi (FIL), file 2259a67e-1527-43ce-990e-13893874ae4f 4
COVID-19 in a Post-transplant Heart Recipient Who Developed Aggressive Lymphoma: A Biphasic Course During Rituximab Treatment, file df5c8818-1251-4a20-92d7-9275b15268b0 3
Early progression as a predictor of survival in marginal zone lymphomas: An analysis from the FIL-NF10 study, file e27ce42f-65b6-2581-e053-d805fe0acbaa 3
Major tumor shrinking and persistent molecular remissions after consolidation with bortezomib, thalidomide, and dexamethasone in patients with autografted myeloma, file e27ce426-d3d4-2581-e053-d805fe0acbaa 2
Integration of COO into the clinical CNS International Prognostic Index could improve CNS relapse prediction in DLBCL, file e27ce42f-25d7-2581-e053-d805fe0acbaa 2
Current treatment strategies with lenalidomide in multiple myeloma and future perspectives., file e27ce435-69b3-2581-e053-d805fe0acbaa 2
Lenalidomide-prednisone induction followed by lenalidomide-melphalan-prednisone consolidation and lenalidomide-prednisone maintenance in newly diagnosed elderly unfit myeloma patients., file e27ce435-7965-2581-e053-d805fe0acbaa 2
Continuous Therapy Versus Fixed Duration of Therapy in Patients With Newly Diagnosed Multiple Myeloma, file 39245075-fb63-4b9f-a5cd-815648491dd1 1
Post-Transplant Lymphoproliferative Disease (PTLD) after Allogeneic Hematopoietic Stem Cell Transplantation: Biology and Treatment Options, file 4b66cb23-dff1-466b-877b-64661647ae65 1
Aspirin or enoxaparin thromboprophylaxis for newly-diagnosed multiple myeloma patients treated with lenalidomide, file e27ce426-d3cf-2581-e053-d805fe0acbaa 1
MET dysregulation is a hallmark of aggressive disease in multiple myeloma patients, file e27ce426-f87d-2581-e053-d805fe0acbaa 1
The hemostatic system and malignancy, file e27ce42d-905c-2581-e053-d805fe0acbaa 1
New approaches to management of multiple myeloma, file e27ce42d-905e-2581-e053-d805fe0acbaa 1
Oral melphalan, prednisone,and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial, file e27ce431-2f9c-2581-e053-d805fe0acbaa 1
Role of Radiotherapy in Post-transplant Lymphoproliferative Disorders: Three Case Reports and Review of the Literature, file e27ce431-eda6-2581-e053-d805fe0acbaa 1
Totale 5.296
Categoria #
all - tutte 6.578
article - articoli 0
book - libri 0
conference - conferenze 335
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.913


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019349 0 0 0 5 11 17 19 60 36 47 91 63
2019/2020693 61 43 40 73 45 52 32 70 93 61 58 65
2020/20211.017 64 68 88 79 68 65 87 102 87 87 102 120
2021/20221.689 125 133 114 186 137 132 155 156 124 99 189 139
2022/20231.118 54 70 150 115 110 90 132 102 71 129 82 13
2023/202473 25 21 27 0 0 0 0 0 0 0 0 0
Totale 5.296